167 related articles for article (PubMed ID: 22156790)
1. Secondary erythromelalgia successfully treated with intravenous immunoglobulin.
Moody S; Pacheco S; Butler IJ; Koenig MK
J Child Neurol; 2012 Jul; 27(7):922-3. PubMed ID: 22156790
[TBL] [Abstract][Full Text] [Related]
2. Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.
Natkunarajah J; Atherton D; Elmslie F; Mansour S; Mortimer P
Clin Exp Dermatol; 2009 Dec; 34(8):e640-2. PubMed ID: 19549232
[TBL] [Abstract][Full Text] [Related]
3. Primary erythromelalgia in a 12-year-old boy: positive response to sodium channel blockers despite negative SCN9A mutations.
Jakob A; Creutzfeldt R; Staszewski O; Winterpacht A; Berner R; Hufnagel M
Klin Padiatr; 2012 Sep; 224(5):309-12. PubMed ID: 22170168
[TBL] [Abstract][Full Text] [Related]
4. [A case of primary erythromelalgia successfully treated with high-dose intravenous immunoglobulin therapy].
Kuroda T; Sugimoto A; Ishigaki S; Murakami H; Kawamura M
Brain Nerve; 2014 Feb; 66(2):185-9. PubMed ID: 24523317
[TBL] [Abstract][Full Text] [Related]
5. Primary erythromelalgia in a child responding to intravenous lidocaine and oral mexiletine treatment.
Nathan A; Rose JB; Guite JW; Hehir D; Milovcich K
Pediatrics; 2005 Apr; 115(4):e504-7. PubMed ID: 15741349
[TBL] [Abstract][Full Text] [Related]
6. Erythromelalgia associated with Clitocybe acromelalga intoxication.
Nakajima N; Ueda M; Higashi N; Katayama Y
Clin Toxicol (Phila); 2013 Jun; 51(5):451-4. PubMed ID: 23641936
[TBL] [Abstract][Full Text] [Related]
7. Topical treatments for erythromelalgia.
Raef HS; Williams M; Fedeles F
Dermatol Ther; 2022 Nov; 35(11):e15860. PubMed ID: 36164837
[TBL] [Abstract][Full Text] [Related]
8. Refractory erythromelalgia of the ears: response to mexiletine.
Vivas AC; Escandon J; Kirsner RS
Am J Otolaryngol; 2011; 32(2):168-70. PubMed ID: 20392536
[TBL] [Abstract][Full Text] [Related]
9. Paediatric hypertension-associated erythromelalgia responds to corticosteroids and is not associated with SCN9A mutations.
Morales PS; Escobar RG; Lizama M; Aglony M; Salomon J; Drenth JP; Borzutzky A
Rheumatology (Oxford); 2012 Dec; 51(12):2295-6. PubMed ID: 22718865
[No Abstract] [Full Text] [Related]
10. A case of secondary erythromelalgia with unusual histological findings.
Bakkour W; Motta L; Stewart E
Am J Dermatopathol; 2013 Jun; 35(4):489-90. PubMed ID: 23334520
[TBL] [Abstract][Full Text] [Related]
11. Secondary erythermalgia in systemic lupus erythematosus; [comment].
Drenth JP; Michiels JJ; van Joost T; Vuzevski VD
J Rheumatol; 1993 Jan; 20(1):144-6. PubMed ID: 8441148
[TBL] [Abstract][Full Text] [Related]
12. Recurrent facial erythema with burning sensation and increased temperature: a variant of erythromelalgia or a new entity?
Luo DQ; Zhao YK; Xu QF; He XQ; Wu LC
Pain Med; 2014 Jun; 15(6):1007-10. PubMed ID: 24433512
[TBL] [Abstract][Full Text] [Related]
13. Painful, reappearing eruption in a medically complex 4-year-old.
Sooy M; Randell RL; Tchapyjnikov D; Werner K; Nazareth-Pidgeon K
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33602765
[TBL] [Abstract][Full Text] [Related]
14. Review of primary and secondary erythromelalgia.
Mann N; King T; Murphy R
Clin Exp Dermatol; 2019 Jul; 44(5):477-482. PubMed ID: 30609105
[TBL] [Abstract][Full Text] [Related]
15. Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7.
Michiels JJ; te Morsche RH; Jansen JB; Drenth JP
Arch Neurol; 2005 Oct; 62(10):1587-90. PubMed ID: 16216943
[TBL] [Abstract][Full Text] [Related]
16. The Complexity of Pain Management in Patients with Erythromelalgia.
Patel N; Chen E; Cucchiaro G
A A Case Rep; 2015 Nov; 5(9):151-3. PubMed ID: 26528699
[TBL] [Abstract][Full Text] [Related]
17. Mexiletine-responsive erythromelalgia due to a new Na(v)1.7 mutation showing use-dependent current fall-off.
Choi JS; Zhang L; Dib-Hajj SD; Han C; Tyrrell L; Lin Z; Wang X; Yang Y; Waxman SG
Exp Neurol; 2009 Apr; 216(2):383-9. PubMed ID: 19162012
[TBL] [Abstract][Full Text] [Related]
18. Erythromelalgia presenting with premature exfoliation of primary teeth: a diagnostic dilemma.
Prabhu N; Alexander S; Wong P; Cameron A
Pediatr Dent; 2012; 34(5):422-6. PubMed ID: 23211921
[TBL] [Abstract][Full Text] [Related]
19. Autonomic dysfunction in SCN9A-associated primary erythromelalgia.
Kim MK; Yuk JW; Kim HS; Park KJ; Kim DS
Clin Auton Res; 2013 Apr; 23(2):105-7. PubMed ID: 23152140
[TBL] [Abstract][Full Text] [Related]
20. An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder.
Meijer IA; Vanasse M; Nizard S; Robitaille Y; Rossignol E
Muscle Nerve; 2014 Jan; 49(1):134-8. PubMed ID: 23893323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
